Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection

NCT01992276 is registered in ClinicalTrials.gov with Crucell Holland BV as lead sponsor.

NCT NCT01992276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01992276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Lead sponsor
Crucell Holland BV
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2013
Completion date
February 28, 2015
Enrollment
0 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

influenza